Study on the efficacy and safety of half-injection recombinant human TNK tissue plasminogen activator throm-bolysis for myocardial reperfusion in elderly patients with acute ST-segment elevation myocardial infarction

CHEN Guo-jun; HUANG Yong-kun; HE Yong-neng; LI Guo-qiang; ZHANG Jian-wu

doi:10.13820/j.cnki.gdyx.20202481

Home>Articles>Study on the efficacy and safety of half-injection recombinant human TNK tissue plasminogen activator throm-bolysis for myocardial reperfusion in elderly patients with acute ST-segment elevation myocardial infarction

DOI: 10.13820/j.cnki.gdyx.20202481

Study on the efficacy and safety of half-injection recombinant human TNK tissue plasminogen activator throm-bolysis for myocardial reperfusion in elderly patients with acute ST-segment elevation myocardial infarction

CHEN Guo-jun

HUANG Yong-kun

HE Yong-neng

LI Guo-qiang

ZHANG Jian-wu

Machine-generated Keywords：

Publication Date：2020-08-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1544-1547 )

Guangdong Medical Journal

PKUISTIC

ISSN：1001-9448

Year, Vol.(Issue)：2020,41(15)